K-numberK254085
Device nameCARTO™ 3 EP Navigation System V9.0 with PIU Plus
ApplicantBiosense Webster, Inc.
Product codeDQK
Device classClass II
Decision dateJan 18, 2026
DecisionSubstantially Equivalent
Regulation870.1425
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The CARTO™ 3 EP Navigation System V9.0 is a catheter-based cardiac mapping system that acquires and displays three-dimensional anatomical and electroanatomical maps of the heart during electrophysiological procedures. It provides real-time information about the electrical activity of the heart and catheter location using magnetic sensor technology and Advanced Catheter Location (ACL) technology, for use in patients eligible for conventional EP procedures.

Technological characteristics

The V9.0 version maintains identical intended use, fundamental scientific technology, magnetic and ACL location mapping technology, and location accuracy as the predicate CARTO™ 3 V8.1. The primary difference is the addition of an improved Patient Interface Unit (PIU Plus) and supporting software modifications; all other hardware components remain unchanged.

Test standards cited

IEC 60601-1 (Medical electrical equipment – General requirements for basic safety and essential performance), IEC 60601-1-2 (Electromagnetic disturbances – Requirements), and IEC 60601-1-6 (Usability). Testing included proof of design, functional verification, unit tests, electrical safety and electromagnetic compatibility testing, and animal testing under simulated clinical conditions.

Substantial equivalence argument

The CARTO™ 3 V9.0 is substantially equivalent to the CARTO™ 3 V8.1 predicate device because it has identical indications for use, the same technological characteristics and scientific principles, an unchanged hardware platform with only an improved Patient Interface Unit, identical location mapping technology and accuracy, and verification and validation testing demonstrating that modifications did not adversely affect existing features or raise new safety or effectiveness concerns.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →